Yiming Pharmaceutical

Yiming Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of high-quality medicines, with a primary focus on oncology, cardiovascular, and anti-infective therapeutic areas. The company operates a robust manufacturing infrastructure that is GMP-certified for both active pharmaceutical ingredients and finished dosage forms. While established as a significant provider of oncology generics, Yiming is increasingly investing in innovative small molecule drug discovery to address unmet medical needs. The company aims to provide affordable and effective treatment options for patients globally by leveraging its integrated R&D and production capabilities. Yiming Pharmaceutical is headquartered in Jiangsu Province and maintains a strong presence in the Chinese domestic market.